JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
SB203580 is a selective ATP-competitive p38 MAPK inhibitor. Enhances the growth of mouse ES cells and enhances differentiation of cardiomyocytes from human ES cells.
SB203580 is a selective ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK2b/p38β2, respectively. SB203580 inhibits LCK, GSK3β and PKBα with IC50s of 100-500-fold higher than that for SAPK2a/p38. SB203580 does not disrupt JNK activity and is an autophagy and mitophagy activator. SB203580 has been shown to enhance clonal growth of skin epithelial progenitor cells and to stimulate neural stem cell (NSC) proliferation. Additionally, SB203580 has also demonstrated significant inhibition of the proliferation of HNSCC cells both in vitro and in vivo.
Download this free eBook from Captivate Bio. We’ve compiled information over the years to help you build on a lab program designed to fit your own needs.
PDF | Download our Small Molecules for Cell and Gene Therapy Research flyer. Now offering RUO and GMP-grade small molecules for a variety of cell types.
PDF | Download The Captivate Bio Access Program flyer and learn more about how we can support small and mid-size life science companies who are looking for immediate access to consulting, marketing, and sales programs.